Mammary Carcinoma: A Specific Biochemical Defect in Autonomous Tumors
- 21 January 1972
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 175 (4019), 335-336
- https://doi.org/10.1126/science.175.4019.335
Abstract
Rat mammary carcinoma (R3230AC) which does not regress after ovariectomy has a markedly reduced amount of cytoplasmic estradiol binding protein. Cytoplasm from the tumor fails to interact with estradiol sufficiently to permit estradiol binding to tumor chromatin. This defect can be corrected in vitro by substituting cytoplasm, containing the binding protein, from rat uterus, thus permitting estradiol binding to tumor chromatin. The results indicate that the hormonal autonomy of this carcinoma is due to a lack of estradiol binding protein and not to the inability of estradiol to interact with the cell genome.Keywords
This publication has 7 references indexed in Scilit:
- A Dissociation Between Ovarian Dependent Growth and Estrogen Sensitivity in Mammary CarcinomaEndocrinology, 1971
- Soluble Complexes between Steroid Hormones and Target-Tissue Receptors Bind Specifically to Target-Tissue ChromatinProceedings of the National Academy of Sciences, 1971
- Tissue specific binding invitro of progesterone-receptor to the chromatins of chick tissuesBiochemical and Biophysical Research Communications, 1971
- Proteins of chromatin in template restriction: I. RNA synthesis in vitroBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1971
- Determination of high-affinity oestrogen-receptor sites in uterine supernatant preparationsBiochemical Journal, 1970
- Estrogen Receptors in the Rat UterusPublished by Elsevier ,1969
- A two-step mechanism for the interaction of estradiol with rat uterus.Proceedings of the National Academy of Sciences, 1968